Literature DB >> 24434140

Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.

Fabao Liu1, Xiaona You2, Xiumei Chi3, Tao Wang2, Lihong Ye4, Junqi Niu5, Xiaodong Zhang6.   

Abstract

The mutant of virus is a frequent event. Hepatitis B virus X protein (HBx) plays a vital role in the development of hepatocellular carcinoma (HCC). Therefore, the identification of potent mutant of HBx in hepatocarcinogenesis is significant. Previously, we identified a natural mutant of the HBx gene (termed HBxΔ127). Relative to wild type HBx, HBxΔ127 strongly enhanced cell proliferation and migration in HCC. In this study, we aim to explore the mechanism of HBxΔ127 in promotion of proliferation of hepatoma cells. Our data showed that both wild type HBx and HBxΔ127 could increase the expression of miR-215 in hepatoma HepG2 and H7402 cells. However, HBxΔ127 was able to significantly increase miR-215 expression relative to wild type HBx in the cells. We identified that protein tyrosine phosphatase, receptor type T (PTPRT) was one of the target genes of miR-215 through targeting 3'UTR of PTPRT mRNA. In function, miR-215 was able to promote the proliferation of hepatoma cells. Meanwhile anti-miR-215 could partially abolish the enhancement of cell proliferation mediated by HBxΔ127 in vitro. Knockdown of PTPRT by siRNA could distinctly suppress the decrease of cell proliferation mediated by anti-miR-215 in HepG2-XΔ127/H7402-XΔ127 cells. Moreover, we found that anti-miR-215 remarkably inhibited the tumor growth of hepatoma cells in nude mice. Collectively, relative to wild type HBx, HBxΔ127 strongly enhances proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT. Our finding provides new insights into the mechanism of HBx mutant HBxΔ127 in promotion of proliferation of hepatoma cells. Crown
Copyright © 2014. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HBx mutant; HCC; Hepatitis B virus X protein; PTPRT; Proliferation; miR-215

Mesh:

Substances:

Year:  2014        PMID: 24434140     DOI: 10.1016/j.bbrc.2014.01.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis.

Authors:  Ming Geng; Xuan Xin; Li-Quan Bi; Lu-Ting Zhou; Xiao-Hong Liu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients.

Authors:  Shu-wei Zhou; Bei-bei Su; Yong Zhou; Yue-qing Feng; Yu Guo; Yun-xiang Wang; Pan Qi; Sheng Xu
Journal:  Med Oncol       Date:  2014-10-01       Impact factor: 3.064

4.  MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.

Authors:  Jing Hu; Tao Sun; Hui Wang; Zhengxin Chen; Shuai Wang; Lifeng Yuan; Tingyu Liu; Hai-Ri Li; Pingping Wang; Yukuan Feng; Qinhong Wang; Roger E McLendon; Allan H Friedman; Stephen T Keir; Darell D Bigner; Jeff Rathmell; Xiang-Dong Fu; Qi-Jing Li; Huibo Wang; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2016-01-11       Impact factor: 31.743

Review 5.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

6.  miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.

Authors:  Yan Hou; Junwen Zhen; Xiaodong Xu; Kun Zhen; Bin Zhu; Rui Pan; Chidong Zhao
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

7.  Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.

Authors:  Linjiang Pan; Suning Huang; Rongquan He; Minhua Rong; Yiwu Dang; Gang Chen
Journal:  Eur J Med Res       Date:  2014-12-02       Impact factor: 2.175

8.  miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.

Authors:  Na Li; Qi-Yue Zhang; Jian-Ling Zou; Zhong-Wu Li; Tian-Tian Tian; Bin Dong; Xi-Juan Liu; Sai Ge; Yan Zhu; Jing Gao; Lin Shen
Journal:  Oncotarget       Date:  2016-01-26

Review 9.  The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis.

Authors:  Li Lin; Xiaomao Yin; Xiumei Hu; Qian Wang; Lei Zheng
Journal:  Tumour Biol       Date:  2014-10-07

10.  Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib.

Authors:  Kazuma Ohyashiki; Tomohiro Umezu; Seiichiro Katagiri; Chiaki Kobayashi; Kenko Azuma; Tetsuzo Tauchi; Seiichi Okabe; Yutaka Fukuoka; Junko H Ohyashiki
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.